Effect of canagliflozin on serum uric acid in patients with type 2 diabetes mellitus

por Davies, M. J., Trujillo, A., Vijapurkar, U., Damaraju, C. V., Meininger, G.
Publicado 2015

Efficacy and safety of canagliflozin over 52 weeks in patients with type 2 diabetes on background metformin and pioglitazone

por Forst, T, Guthrie, R, Goldenberg, R, Yee, J, Vijapurkar, U, Meininger, G, Stein, P
Publicado 2014